Author

Xin V. Li

Harold C. Simmons Comprehensive Cancer CenterORCID 0000-0002-9444-8214Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Cancer Biology· 1 Immunology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Organism:mouse· 2 Assay:bulk RNA-seq· 1 Research Focus:cancer & tumor microenvironment· 1 Research Focus:cell type annotation· 1 Research Focus:cell-cell communication· 1 Research Focus:drug response / drug discovery· 1 Research Focus:host-pathogen & immune response· 1

Frequent Co-Authors

Andrew Young KohiD· 2 shared Christina M. ZarekiD· 2 shared Hesuiyuan Wang· 2 shared Jake N. LichtermaniD· 2 shared Jiwoong KimiD· 2 shared Nicole A. PoulidesiD· 2 shared Parastoo SabaeifardiD· 2 shared Tarun SrinivasaniD· 2 shared

Activity by Year

2025-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCancer Biology

Andrew Young KohORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Cancer BiologybioRxivPreprintApr 19, 2026

A microbiota-derived bile acid overcomes antibiotic-induced hyporesponsiveness to immune checkpoint therapy by enhancing CD8+ T cell antitumor immunity

Wenling Li, Christina M. Zarek, Hesuiyuan Wang…·Andrew Young Koh

This study identifies TDCA, a microbiota-derived bile acid, as a mediator that restores immune checkpoint therapy efficacy after antibiotic-induced hyporesponsiveness by enhancing CD8+ T cell antitumor immunity.

1 citation

mouseproteomics

𝕏 PostBluesky

ImmunologybioRxivPreprintNov 3, 2025

Timing of immune checkpoint blockade shapes anti-tumor immunity via a clock-dependent chemokine axis

Jake N. Lichterman, Tarun Srinivasan, Ruheng Wang…·Andrew Young Koh

This study shows that the time of day affects cancer immunotherapy efficacy through a circadian clock-dependent chemokine axis in mice.

3 citations

mousebulk RNA-seq

𝕏 PostBluesky